ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

MLAB Mesa Laboratories Inc

91,48
0,20 (0,22%)
Dernière mise à jour : 18:56:50
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Mesa Laboratories Inc MLAB NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,20 0,22% 91,48 18:56:50
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
90,37 90,04 92,00 91,28
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
17/6/202419:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202417:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202417:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202415:44EDGAR2Form NT 10-K - Notification of inability to timely file Form..
05/6/202412:03EDGAR2Form 8-K - Current report
05/6/202412:00GLOBEMesa Labs Announces Fourth Quarter and Full Fiscal Year 2024..
31/5/202412:00GLOBEMesa Laboratories, Inc. Revises Earnings Announcement date..
24/5/202414:42IHMARKETNEWSU.S. Index Futures Show Pre-Market Gains, Oil Prices Fall
22/5/202412:00GLOBEMesa Laboratories, Inc. Revises Earnings Announcement date..
08/4/202414:00GLOBEMESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND..
05/4/202400:24GLOBEMESA LABS DECLARES QUARTERLY DIVIDEND
01/4/202416:27GLOBEMesa Laboratories, Inc. to Announce Unaudited Fourth Quarter..
15/3/202412:00GLOBEMesa Labs Releases Second Annual Responsible Business..
16/2/202419:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202417:37EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/2/202414:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/2/202414:00EDGAR2Form 8-K - Current report
05/2/202414:00GLOBEMesa Labs Announces Third Quarter Results
23/1/202420:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202414:00EDGAR2Form 8-K - Current report
08/1/202414:00GLOBEMesa Laboratories Appoints Mark Capone to its Board of..
05/1/202415:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
04/1/202421:00GLOBEMESA LABS DECLARES QUARTERLY DIVIDEND
03/1/202414:00GLOBEMesa Labs Completes the Acquisition of GKE Science &..
19/12/202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202316:21EDGAR2Form 144 - Report of proposed sale of securities
14/12/202316:47GLOBEMesa Laboratories, Inc. to Announce Second Quarter Results..
14/11/202312:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202314:00EDGAR2Form 8-K - Current report
06/11/202314:00GLOBEMesa Labs Announces Second Quarter Results
18/10/202319:26EDGAR2Form 8-K - Current report
16/10/202309:00GLOBEMesa Labs Acquires GKE-GmbH Complementary Sterilization..
10/10/202318:42EDGAR2Form 8-K - Current report
03/10/202314:00GLOBEMESA LABS DECLARES QUARTERLY DIVIDEND
19/9/202318:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202319:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202322:44EDGAR2Form 144 - Report of proposed sale of securities
13/9/202319:37GLOBEMesa Laboratories, Inc. to Announce Second Quarter Results..
06/9/202318:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202318:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202318:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202318:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202317:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202322:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/9/202318:45EDGAR2Form 144 - Report of proposed sale of securities
30/8/202321:31EDGAR2Form 8-K - Current report